NYSE · Financial Statements

Guardian Pharmacy Services, Inc. (GRDN) Financial Statements

$39.44 NYSE: GRDN Market Cap $2.50B

Guardian Pharmacy Services, Inc. most recently reported annual revenue of $1.4B, net profit of $49.0M. Revenue grew at an average annual rate of 14.5% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Guardian Pharmacy Services, Inc.: Revenue rose from $600.0M in 2018 to $1.4B in 2025, a change of +141.5% over 7 years; net profit was positive in 7 of 8 reported years; operating margin moved from 4.3% to 6.1%, a shift of +1.8 percentage points; the most recent year shows net profit of $49.0M.

Income Statement — 8 Years (USD millions)

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	$600.0M	$698.0M	$736.0M	$792.0M	$909.0M	$1.0B	$1.2B	$1.4B
Operating Expenses	$574.0M	$664.0M	$704.0M	$762.0M	$857.0M	$1.0B	$1.3B	$1.4B
Operating Profit	$26.0M	$34.0M	$32.0M	$30.0M	$52.0M	$41.0M	$-63.0M	$89.0M
Operating Margin	4.3%	4.9%	4.4%	3.8%	5.7%	3.9%	-5.1%	6.1%
Other Income	$-3.0M	$-3.0M	$-2.0M	$-2.0M	$-2.0M	$-3.0M	$-4.0M	$-15.0M
Interest	$2.0M	$2.0M	$2.0M	$2.0M	$2.0M	$3.0M	$3.0M	$1.0M
Depreciation	$13.0M	$16.0M	$17.0M	$17.0M	$17.0M	$18.0M	$20.0M	$22.0M
Profit Before Tax	$23.0M	$31.0M	$30.0M	$28.0M	$50.0M	$38.0M	$-66.0M	$73.0M
Tax	$0	$0	$0	$0	$0	$0	$-6.8M	$33.3M
Net Profit	$15.0M	$22.0M	$20.0M	$16.0M	$35.0M	$24.0M	$-87.0M	$49.0M
EPS	$0.24	$0.36	$0.33	$0.27	$0.58	$0.39	$-1.77	$0.78
Dividend Payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

Metric	Sep '23	Dec '23	Mar '24	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
Revenue	$263.0M	$281.0M	$275.0M	$300.0M	$314.0M	$339.0M	$329.0M	$344.0M	$377.0M	$398.0M	$337.0M	$352.0M
Operating Expenses	$269.0M	$266.0M	$267.0M	$283.0M	$419.0M	$322.0M	$316.0M	$332.0M	$361.0M	$361.0M	$319.0M	$331.0M
Operating Profit	$-6.0M	$16.0M	$8.0M	$17.0M	$-105.0M	$17.0M	$13.0M	$13.0M	$17.0M	$37.0M	$18.0M	$21.0M
Operating Margin	-2.4%	5.5%	2.9%	5.7%	-33.3%	5.0%	4.0%	3.6%	4.5%	9.2%	5.3%	5.9%
Interest	$1.0M	$1.0M	$1.0M	$1.0M	$1.0M	$0	$0	$0	$0	$0	$0	$0
Profit Before Tax	$-7.0M	$15.0M	$7.0M	$16.0M	$-106.0M	$16.0M	$13.0M	$13.0M	$17.0M	$31.0M	$18.0M	$30.0M
Tax	$0	$0	$0	$0	$-170,000	$27.0M	$29.3M	$29.9M	$42.3M	$31.6M	$26.0M	$25.8M
Net Profit	$-11.0M	$12.0M	$3.0M	$11.0M	$-113.0M	$12.0M	$9.0M	$9.0M	$10.0M	$21.0M	$13.0M	$22.0M
EPS	$-0.19	$0.38	$-0.14	$0.17	$-2.00	$0.20	$0.15	$0.14	$0.15	$0.33	$0.21	$0.34

Over the 8 years reported for Guardian Pharmacy Services, Inc., borrowings decreased from $44.0M in 2018 to $37.0M in 2025, cash stood at $66.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.38 times.

Balance Sheet — 8 Years (USD millions)

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	$182.0M	$197.0M	$218.0M	$236.0M	$256.0M	$271.0M	$321.0M	$413.0M
Current Assets	$81.0M	$90.0M	$94.0M	$112.0M	$120.0M	$130.0M	$152.0M	$222.0M
Cash	$2.0M	$0	$6.0M	$15.0M	$1.0M	$1.0M	$5.0M	$66.0M
Inventory	$28.0M	$31.0M	$32.0M	$33.0M	$41.0M	$37.0M	$41.0M	$43.0M
Receivables	$48.0M	$54.0M	$46.0M	$55.0M	$68.0M	$77.0M	$97.0M	$102.0M
Fixed Assets	$28.0M	$35.0M	$52.0M	$52.0M	$65.0M	$73.0M	$79.0M	$90.0M
Capital Work in Progress	$0	$0	$0	$0	$0	$0	$0	$0
Investments	$0	$0	$0	$0	$0	$0	$0	$0
Other Assets	$48.0M	$46.0M	$52.0M	$55.0M	$56.0M	$56.0M	$69.0M	$80.0M
Total Liabilities	$114.0M	$139.0M	$151.0M	$183.0M	$180.0M	$211.0M	$171.0M	$195.0M
Current Liabilities	$65.0M	$90.0M	$86.0M	$112.0M	$112.0M	$138.0M	$144.0M	$161.0M
Borrowings	$44.0M	$57.0M	$59.0M	$55.0M	$63.0M	$69.0M	$30.0M	$37.0M
Other Liabilities	$70.0M	$82.0M	$92.0M	$127.0M	$117.0M	$142.0M	$141.0M	$158.0M
Equity	$34.0M	$30.0M	$39.0M	$24.0M	$43.0M	$28.0M	$0	$0
Reserves	$34.0M	$0	$38.0M	$24.0M	$43.0M	$28.0M	$143.0M	$206.0M

For Guardian Pharmacy Services, Inc., operating cash flow was positive in 8 of 8 reported years; free cash flow in the latest year was $81.0M; free cash flow was positive in 8 of 8 years; financing activities used $30.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 8 Years (USD millions)

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Operating Cash Flow	$44.0M	$56.0M	$53.0M	$58.0M	$49.0M	$71.0M	$58.0M	$100.0M
Investing Cash Flow	$-31.0M	$-31.0M	$-21.0M	$-22.0M	$-35.0M	$-28.0M	$-47.0M	$-52.0M
Financing Cash Flow	$-9.0M	$-10.0M	$-10.0M	$-13.0M	$-11.0M	$-16.0M	$-71.0M	$-30.0M
Net Cash Flow	$2.0M	$-2.0M	$6.0M	$9.0M	$-14.0M	$0	$4.0M	$61.0M
Free Cash Flow	$34.0M	$42.0M	$44.0M	$49.0M	$32.0M	$56.0M	$42.0M	$81.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.14
EV / EBITDA	23.06
FCF Yield	2.97%
Quick Ratio	1.33
Interest Coverage	145.39
Return 1Y	95.62%
Return 3Y	—
Return 5Y	—

Guardian Pharmacy Services, Inc. (GRDN) financials — frequently asked questions

What is Guardian Pharmacy Services, Inc.'s annual revenue?

Guardian Pharmacy Services, Inc. (GRDN) reported annual revenue of $1.4B in its most recent fiscal year.

What is Guardian Pharmacy Services, Inc.'s net profit?

Guardian Pharmacy Services, Inc. (GRDN) reported net profit of $49.0M in its most recent fiscal year.

What is GRDN EV/EBITDA?

Guardian Pharmacy Services, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 23.06.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks NYSE High ROE Stocks All stock screens

GRDN Overview GRDN Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.